Cytokine Registry Database of Stroke Patients

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Acute StrokeAcute Ischemic StrokeIschemic StrokeHemorrhagic Stroke
Interventions
OTHER

Serum and Urine measurement of cytokines.

To evaluate serum cytokine levels and identifying serum inflammatory markers (serum interleukin-33, IL-37, IL-36, IL-4, IL-6, IL-10, IL-17, IL-23, IL-1, TNF, PDGF, VEGFM TNFa, ANNULIN, MMP-9, MMP-12, NFk-B levels plus metabolic products like MPO, etc and glial factors like GMF, SI000B, GM6001) in patients with acute ischemic \& hemorrhagic stroke.

Trial Locations (1)

87131-0007

Department of Neurology, University of New Mexico, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER

NCT03297827 - Cytokine Registry Database of Stroke Patients | Biotech Hunter | Biotech Hunter